Cargando…

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

After the publication of an article discussing the methodological options to detect the diversion potential of prescription drugs, this letter presents the multidimensional functioning of the French Addictovigilance System. This system aims at monitoring all substances with abuse potential, relying...

Descripción completa

Detalles Bibliográficos
Autores principales: Jouanjus, Emilie, Micallef, Joëlle, Mallaret, Michel, Lapeyre-Mestre, Maryse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672683/
https://www.ncbi.nlm.nih.gov/pubmed/31194866
http://dx.doi.org/10.1093/ijnp/pyz033
_version_ 1783440580662001664
author Jouanjus, Emilie
Micallef, Joëlle
Mallaret, Michel
Lapeyre-Mestre, Maryse
author_facet Jouanjus, Emilie
Micallef, Joëlle
Mallaret, Michel
Lapeyre-Mestre, Maryse
author_sort Jouanjus, Emilie
collection PubMed
description After the publication of an article discussing the methodological options to detect the diversion potential of prescription drugs, this letter presents the multidimensional functioning of the French Addictovigilance System. This system aims at monitoring all substances with abuse potential, relying on a network of experts specialized in clinical and fundamental pharmacology. For more than 25 years, we have created collaborations with partners at the interface with field data related to substance use and the potential related disorders. When relevant depending on the context, these data sources are explored and crossed to analyze the abuse potential of one given substance. This organizational approach is useful to detect early Addictovigilance warning signals and to take appropriate measures. Generalizing such a multidimensional approach outside France appears an appealing option to move towards more effective Addictovigilance systems at the international level.
format Online
Article
Text
id pubmed-6672683
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-66726832019-08-05 Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions Jouanjus, Emilie Micallef, Joëlle Mallaret, Michel Lapeyre-Mestre, Maryse Int J Neuropsychopharmacol Letter to Editor After the publication of an article discussing the methodological options to detect the diversion potential of prescription drugs, this letter presents the multidimensional functioning of the French Addictovigilance System. This system aims at monitoring all substances with abuse potential, relying on a network of experts specialized in clinical and fundamental pharmacology. For more than 25 years, we have created collaborations with partners at the interface with field data related to substance use and the potential related disorders. When relevant depending on the context, these data sources are explored and crossed to analyze the abuse potential of one given substance. This organizational approach is useful to detect early Addictovigilance warning signals and to take appropriate measures. Generalizing such a multidimensional approach outside France appears an appealing option to move towards more effective Addictovigilance systems at the international level. Oxford University Press 2019-06-13 /pmc/articles/PMC6672683/ /pubmed/31194866 http://dx.doi.org/10.1093/ijnp/pyz033 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter to Editor
Jouanjus, Emilie
Micallef, Joëlle
Mallaret, Michel
Lapeyre-Mestre, Maryse
Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
title Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
title_full Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
title_fullStr Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
title_full_unstemmed Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
title_short Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
title_sort comment on: an insight into z-drug abuse and dependence: an examination of reports to the european medicines agency database of suspected adverse drug reactions
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672683/
https://www.ncbi.nlm.nih.gov/pubmed/31194866
http://dx.doi.org/10.1093/ijnp/pyz033
work_keys_str_mv AT jouanjusemilie commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions
AT micallefjoelle commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions
AT mallaretmichel commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions
AT lapeyremestremaryse commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions